BioCentury
ARTICLE | Company News

Alcon, Sirion sales and marketing update

April 5, 2010 7:00 AM UTC

Alcon completed its previously announced acquisition of exclusive, U.S. rights to Durezol difluprednate from Sirion. Alcon also received exclusive, worldwide rights, excluding Latin America, to devel...